Back to mobile site

Benchmark Reiterates Hold Rating on RXO, Inc. (RXO) Following Jury Verdict in Lipe v. Lupus Superior

July 28, 2026 10:22 AM EDT Send to a Friend
Benchmark analyst Christopher Kuhn reiterated a Hold rating on RXO, Inc. (NYSE: RXO).The analyst commented, "RXO's valuation has become more ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login